MICHAEL R DOUGHERTY Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL R DOUGHERTY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL R DOUGHERTY. MICHAEL R DOUGHERTY is Director in Aviragen Therapeutics, Inc. ($NABI) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in Celator Pharmaceuticals Inc ($CPXX) and Executive Chairman in Celator Pharmaceuticals Inc ($CPXX) and Director in TREVENA INC ($TRVN) and Director in CEMPRA, INC. ($CEMP) and Director in Foundation Medicine, Inc. ($FMI).
MICHAEL R DOUGHERTY in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL R DOUGHERTY: Director
Holdings: 37,645 shares
Current Value: $58,726
Latest Transaction: Jan 06 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL R DOUGHERTY in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CPXX, FMI, IDRA, MRNS, MLNT, TRVN, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 4.02 | 3,515 | 14,130 | 37,645 | 34.1 K to 37.6 K (+10.30 %) |
| Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 1.79 | 7,193 | 12,875 | 28,408 | 21.2 K to 28.4 K (+33.91 %) |
| May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
| Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 1.28 | 10,059 | 12,876 | 21,215 | 11.2 K to 21.2 K (+90.17 %) |
| Oct 02 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 2.67 | 4,119 | 10,998 | 4,119 | 0 to 4.1 K |
| Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
| Apr 10 2019 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.66 | 23,000 | 61,180 | 23,000 |
Page: 1